AUG 14, 2026 · PHASE 1/2 TRIAL
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
ClinicalTrials.gov
This is an active Phase 1/2 interventional trial registered before results are available; no efficacy or safety data are reported in this registry record.
Reported
Planned enrollment105
Study phasePhase 1/2
Primary endpoint (Part A)Frequency of Adverse Events, up to 9 months